Download NT Pro B-Type Natriuretic Peptide (NTproBNP)

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Epidemiology of metabolic syndrome wikipedia , lookup

Prenatal testing wikipedia , lookup

Fetal origins hypothesis wikipedia , lookup

Seven Countries Study wikipedia , lookup

List of medical mnemonics wikipedia , lookup

Transcript
NT Pro B-Type Natriuretic
Peptide (NTproBNP)
GP information sheet
February 2013
NT Pro B-Type Natriuretic Peptide (NTproBNP)
Natriuretic Peptides
The use of natriuretic peptide measurements to act as an
initial “rule-out” test for chronic heart failure in primary care
has been recommended by NICE1.
Both B-type natriuretic peptide (BNP) and the inactive N
terminal portion of the pro hormone (NTproBNP) have both
been recommended for this purpose. NTproBNP has superior
stability in serum and is the peptide of choice.

Therefore NTproBNP will be the test provided for the
investigation of heart failure.
Diagnosing Heart Failure Pathway
The Nottinghamshire CHD network has proposed an
algorithm for the diagnosis of Heart failure in primary care
based on NICE1 guidance (next page)
However, NICE cut off’s for NTproBNP are higher than in
some published articles2. The higher cut off values used by
NICE and the Nottinghamshire CHD Network guidance
improves specificity of NTproBNP for the diagnosis of heart
failure but as a consequence leads to a loss in sensitivity of
the NTproBNP test for screening purposes. This means it is
possible that up to 25% of patients with chronic heart failure
may be missed by NTproBNP screening.



Please note that NTproBNP can be elevated in conditions
other than heart failure such as Left ventricular
hypertrophy, ischaemia, tachycardia, right ventricular
overload, hypoxaemia including PE, GFR<60mL/minute,
sepsis, COPD, diabetes, age >70 and liver cirrhosis.
Obesity, diuretics, ACE inhibitors, beta blockers,
angiotensin receptor blockers (ARB’s) and aldosterone
antagonists can reduce NTproBNP levels.
Thus in the interpretation of NTproBNP levels NICE cut
off levels should be used initially, but drug therapy, age,
other conditions and clinical suspicion should be taken
into account.
Interpretation:
A routine serum clotted sample (gold top tube) is
required for analysis. Request either using ICE or
on a red Haematology/Biochemistry request
form. The following comments will be attached to
results:

NTproBNP <47pmol/L (Normal levels)
Values up to 47pmol/L mean that heart failure is a
very unlikely cause of patient symptoms. Obesity,
diuretics, ACE inhibitors, beta blockers
angiotensin receptor blockers and aldosterone
antagonists can reduce NTproBNP levels.

NTproBNP >47pmol/L and <236pmol/L
NTproBNP values above 47pmol/L are compatible
with heart failure and further investigation is
suggested

NTproBNP>236pmol/L
NTproBNP >236pmol/L are compatible with heart
failure and indicate a poor prognosis. Suggest
urgent referral to the cardiology team for ECHO
and further investigation.
Contact details
Clinical Chemistry: [email protected]
Dr Firial Al Ubaidi 01623 622515 3606
Dr Melanie Griffiths 01623 622515 3611
Francesca Meakin 016230622515 6416
1 NICE Clinical Guideline 108. Chronic Heart Failure:
Management of chronic heart failure in adults in primary and
secondary care.
2 Hildebrandt P, Collinson PO, Doughty RN, et al; Agedependent values of N terminal pro B type Natriuretic peptide
are superior to a single cut point for ruling out suspected
systolic dysfunction in primary care. European Heart Journal
2010: 31; 1881-1889
Laboratory Medicine working for local people
Laboratory Medicine Working for Local People
Nottinghamshire CHD Network: Diagnosing Heart Failure Pathway
Diagnosing heart failure
Detailed History and perform a clinical examination with suspected Heart
failure
Initial investigations- ECG & Appropriate Blood test
i.e. FBC, U&Es,LFT, Thyroid function, fasting lipids, fasting glucose
Previous MI within 12 months with
No Previous MI
Abnormal BNP
no previous echo
Levels
Perform
Echo
Abnormal
BNP
High/Raised
BNP Test
Consider BNP
Test if levels
NOT KNOWN
Echo Clear
of Abnormality
Normal BNP
Levels
Raised Levels
Assess Severity, aetiology , type of
cardiac dysfunction, correctable causes
Other Cardiac
abnormality
Angina or
Valvular Heart
Disease
Cardiology
Referral
Investigate other
causes
HF with
preserved
ejection
fraction
HF due to
LVSD
Primary Care HF
Management
Guidelines
HF unlikely
consider
other
diagnosis
Primary Care Management manage co morbid
conditions such as High BP,
Ischaemic Heart Disease &
Diabetes
Consider other
treatment
Serum natriuretic peptides –NTproBNP definitions
High Levels – NTproBNP>2000pg/ml(236pmol/litre
NTproBNP
Raiseddefinitions
levels- NTproBNP 400-2000 pg/ml(47-236pmol/litre)



Normal
levels – NTproBNP<400pg/ml(47pmol/litre)
High Levels
NTproBNP
>236pmol/L
Raised Levels
NTproBNP 47-236pmol/L
Normal Levels
NTproBNP <47pmol/L
BNP PathwayU080312
ENTER Month/year
Medicine
LaboratoryLaboratory
Medicine Working
for Localworking
People for local people